ECB Bancorp, Inc. filed a Form 8-K on September 22, 2026, disclosing that its Board of Directors appointed Matthew J. Cushing as a director of the company and its wholly owned subsidiary, Everett Co-operative Bank, effective September 16, 2026.
Agree Realty Corporation filed an 8-K with the Securities and Exchange Commission on September 22, 2026, disclosing that its subsidiary Agree Limited Partnership completed an underwritten public offering of $400 million in senior unsecured notes maturing October 15, 2036.
Tenet Healthcare Corporation filed a current report on September 22, 2026, disclosing the issuance of $2,000,000,000 in aggregate principal amount of 6.250% senior notes due 2034 and its plans to use the proceeds to redeem existing senior notes.
GE HealthCare Technologies Inc. filed a current report on September 22, 2026, disclosing the appointment of Pascal Desroches as a new member of its Board of Directors, effective January 4, 2027.
Sky Quarry Inc. filed a Form 8-K on September 22, 2026, reporting the final voting results from its special meeting of stockholders held on September 18, 2026, at which four proposals were considered, including two reverse stock split authorizations and a new omnibus incentive …
Star Equity Holdings, Inc. filed a current report on Form 8-K with the SEC on September 22, 2026, furnishing an investor presentation covering the company's business and operations as of June 30, 2026.
The company formerly known as Domo, Inc. filed an 8-K on September 22, 2026, reporting the completion of the sale of substantially all of its assets and employees to Progress Software Corporation, its subsequent renaming to Huckleberry.ai, Inc., and the termination of its existing …
Beyond Meat, Inc. filed a Form 8-K with the SEC on September 22, 2026, disclosing that a federal court entered a judgment of $15,437,500 against the company on September 18, 2026, following post-trial rulings in a trademark infringement case brought by Sonate Corporation.
ProPetro Holding Corp. filed a Form 8-K with the SEC on September 22, 2026, disclosing that its wholly owned subsidiary has entered into contracts to commit approximately 230 megawatts of power generation capacity to a subsidiary of Targa Resources Corp.
TriSalus Life Sciences, Inc. filed a Form 8-K with the SEC on September 22, 2026, disclosing that it received U.S. Food and Drug Administration 510(k) clearance for its TriNav Advance device and expects to commence commercialization.